The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 08, 2020
Filed:
Dec. 04, 2014
Applicant:
Galderma Research & Development, Biot, FR;
Inventors:
Claire Mallard, Mougins, FR;
Carole Dubayle, Mouans-Sartoux, FR;
Assignee:
GALDERMA RESEARCH & DEVELOPMENT, Biot, FR;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 8/11 (2006.01); A61K 47/14 (2017.01); A61K 47/24 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 31/402 (2006.01); A61Q 19/00 (2006.01); A61K 31/192 (2006.01); A61K 8/37 (2006.01); A61K 31/203 (2006.01); A61K 8/67 (2006.01); A61K 8/86 (2006.01); A61K 31/216 (2006.01); A61K 9/50 (2006.01); A61K 8/55 (2006.01); A61K 9/107 (2006.01); A61K 31/05 (2006.01); A61K 31/12 (2006.01); A61K 31/5575 (2006.01); A61K 31/573 (2006.01); A61K 9/08 (2006.01); A61K 47/10 (2017.01);
U.S. Cl.
CPC ...
A61K 8/11 (2013.01); A61K 8/37 (2013.01); A61K 8/375 (2013.01); A61K 8/553 (2013.01); A61K 8/671 (2013.01); A61K 8/86 (2013.01); A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 9/08 (2013.01); A61K 9/107 (2013.01); A61K 9/5015 (2013.01); A61K 31/05 (2013.01); A61K 31/12 (2013.01); A61K 31/192 (2013.01); A61K 31/203 (2013.01); A61K 31/216 (2013.01); A61K 31/402 (2013.01); A61K 31/5575 (2013.01); A61K 31/573 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61K 47/24 (2013.01); A61Q 19/00 (2013.01); A61K 2800/412 (2013.01);
Abstract
Lipid microcapsules are described that can include at least one lipophilic active substance, more specifically a retinoid, in a soluble form. Also described, are pharmaceutical compositions including the same and a method for the production thereof. Methods of using such a composition to treat dermatological pathologies are also described.